Table 5.

Recently reported miRNAs in HCC therapy resistance.

Drug	miRNA	Target	Reference
Cisplatin	miR-33a-5p	SOCS3	[220,221]
	miR-363	MCL1	[223]
Doxorubicin	miR-133a	ABC subfamily C1	[224]
	miR-326	ABC subfamily C1	[224]
5-FU	miR-141	Kelch-like ECH-associated protein 1 (KEAP1), Nuclear factor erythroid 2 like 2 (NFE2L2)	[225]
	miR-125b	BCL2	[14]
	miR-195	BCL2	[14]
	miR-503	eukaryotic translation initiation factor 4E (EIF4E)	[228]
Sorafenib	miR-93	p21Cip/Waf1	[222]
	miR-181	Ras association domain family 1 (RASSF1)	[230]
	miR-216a	p21Cip/Waf1	[222]
	miR-217	p21Cip/Waf1	[222]
	miR-494	PTEN, mTOR	[231]